Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2896 of 5804
-
New combo tackles returning bone cancer before surgery
Disease control OngoingThe purpose of this study is to evaluate the safety and efficacy of nivolumab, or nivolumab in combination with azacitidine in participants with recurrent, resectable osteosarcoma
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New PET scan could reveal which kidney cancer patients respond to immunotherapy
Knowledge-focused OngoingThis is an exploratory clinical trial to assess the potential of 89Zr-DFO-Atezolizumab Positron Emission Tomography/Computed Tomography (PET/CT) scans in patients with locally advanced or metastatic renal cell carcinoma (RCC). This open label, nontherapeutic trial will test the c…
Phase: PHASE2 • Sponsor: James Brugarolas • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Gentle vibration may ease joint pain in breast cancer survivors
Symptom relief CompletedThe purpose of this study is to compare the effect of low intensity vibration (LIV) delivered for 10 minutes twice daily for 12 months on skeletal muscle function, in terms of energetic capacity measured by power generation on a stationary bicycle, among patients with early stage…
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New combo therapy aimed at Hard-to-Treat liver disease
Disease control TerminatedStudy to evaluate the efficacy, safety, and tolerability of investigational drug obeticholic acid (OCA) in combination with the investigational drug bezafibrate (BZF) in participants with Primary Biliary Cholangitis (PBC).
Phase: PHASE2 • Sponsor: Intercept Pharmaceuticals • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can a mask prevent breathing failure in obese ICU patients?
Disease control CompletedMechanical ventilation is the first artificial support used in intensive care. After a period of invasive mechanical ventilation, patients should be separated from the ventilator (weaning period of mechanical ventilation). If weaning and extubation (removal of the tracheal tube) …
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple back injection replace morphine after kidney stone surgery?
Symptom relief CompletedThis study is planned as a single-center randomized single blinded study and includes patients undergoing percutaneous nephrolitotomy.The aim of the study is to evaluate the effect of ultrasound guided erector spinal plane block on postoperative analgesia in percutaneous nephroli…
Phase: NA • Sponsor: Istanbul University • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Brain fatigue after thyroid disease: immune system may be to blame
Knowledge-focused Recruiting nowMental fatigue occurs in many diseases and the reasons are mostly unknown. The investigators hypothesize that remaining mental fatigue after restored hyperthyroidism in Graves' disease is an autoimmune complication. The aim of this study is to explore immunological markers possib…
Sponsor: Vastra Gotaland Region • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Cochlear implant users train with music to boost hearing and enjoyment
Knowledge-focused CompletedThis project aims to characterize the emergence of music appreciation in people who have suffered hearing loss and have been provided with partial restoration of hearing through cochlear implantation. Music appreciation is complex and transverses multiple domains including hearin…
Phase: NA • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Single-Dose breast radiation may cut fatigue in half
Symptom relief TerminatedBreast cancer is the most frequent malignancy in women. Standard therapy for early-stage breast cancer is breast conserving surgery (BCS) followed by adjuvant whole breast irradiation (WBI), which usually requires a treatment time of 3-6 weeks. Several randomized controlled trial…
Phase: NA • Sponsor: University Hospital Heidelberg • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Simple tests may predict ACL repair failure in young athletes
Knowledge-focused CompletedIn this longitudinal prospective cohort study including young people with anterior cruciate ligament (ACL) reconstruction, the investigators will evaluate if poor sensorimotor function at baseline can predict 1) graft rupture 2) the risk of contra-lateral ACL injury and 3) failur…
Sponsor: Umeå University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New study aims to unlock secrets of heart transplant failure
Knowledge-focused Recruiting nowThe investigators will evaluate for early evidence of cardiac allograft dysfunction by cardiac MRI and single cell sequencing to determine underlying molecular and macroscopic causes.
Phase: PHASE4 • Sponsor: Paul Kim • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Heart device under surveillance: 500 patients tracked for safety
Disease control CompletedThe purpose of the Amplatzer PFO Occluder post-marketing clinical use surveillance study is to observe the frequency, type and degree of adverse device effects and adverse events in order to assure the safety of the new medical device, and to collect safety and efficacy informati…
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New lupus drug shows promise in early safety trial
Disease control CompletedThis is a multi-center study to evaluate the safety, tolerability, PK, PD, and clinical activity of itolizumab (EQ001) in subjects with Systemic Lupus Erythematosus with or without Active Proliferative Lupus Nephritis
Phase: PHASE1 • Sponsor: Biocon Limited • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Headband could spot deadly brain vessel spasms before they strike
Diagnosis CompletedTranscranial Doppler ultrasound (TCD) monitoring and CT-scanner perfusion are useful but imperfect tools to identify vasospasm and allow intervention to avoid infarction. Permanent monitoring of cerebral tissue oximetry (rSO2) by NIRS, a noninvasive method could allow better vas…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New device aims to clear lungs better in cystic fibrosis
Symptom relief CompletedThe main objective of the study is to evaluate the short-term effects of the airway clearance technique by the medical device Simeox (Physio Assist, France) versus Autogenic Drainage, on the pulmonary function of adult patients with stable cystic fibrosis. To analyse these effect…
Phase: NA • Sponsor: Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Could a belly pain pump replace narcotics after hysterectomy?
Symptom relief Recruiting nowThe study is a prospective, double-blinded, placebo-controlled multi-center trial to measure if postoperative pain and the amount of narcotics used are reduced by a clinically significant amount in women undergoing minimally invasive hysterectomy receiving a continuous infusion o…
Phase: PHASE4 • Sponsor: Ying Liu • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Better brain zaps: new study tests precision targeting for depression treatment
Disease control OngoingRepetitive pulse transcranial magnetic stimulation (rTMS) is a noninvasive treatment that involves stimulating the brain; however, treatment benefit depends on placing a TMS coil in the correct place on the head to reach critical brain regions below. Clinicians typically use scal…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New hope for rare lymphoma: lorlatinib trial targets Drug-Resistant cancers
Disease control CompletedThe purpose of this study is to define the objective response rates (ORR) of Lorlatinib in subjects with ALK+ lymphomas resistant or refractory to ALK inhibitors.
Phase: PHASE2 • Sponsor: University of Milano Bicocca • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Toddler anxiety tackled: new therapy shows promise for 2-Year-Olds
Symptom relief OngoingThe purpose of this study is to test the feasibility and efficacy of intervening with 2-year-old children with elevated temperamental Fear and/or Shyness or 3-year-old children with elevated anxiety and their parents, using a parent-child Cognitive Behavioral Therapy (CBT) protoc…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Gene therapy survivors monitored for decades in new study
Knowledge-focused ENROLLING_BY_INVITATIONThis observational long-term follow-up study is designed to collect safety and efficacy data from ADA-SCID patients previously treated with autologous ex vivo gene therapy products based on the EFS-ADA LV encoding for human adenosine deaminase (ADA) gene (EFS-ADA LV), as part of …
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC